Hybrid Versus Synthetic TOT for Treatment of SUI
Hybrid Versus Synthetic Transobturator Tape for Treatment of Female Stress Urinary Incontinence: Prospective Randomised Study
1 other identifier
interventional
50
1 country
1
Brief Summary
This prospective study is conducted on female patients presenting with SUI at Alexandria main university hospital. Patients with neurogenic voiding dysfunction, history of anti-incontinence surgery, urge-predominant MUI, urogenital cancer, pelvic irradiation, body mass index more than 40 kg/m2 and more than stage 1 POP are excluded. Patients are randomized into 2 groups, one group will be subjected to h\_TOT, and the second group to conventional TOT. Patients are subjected to PGI and UDI-6 questionnaires and a urodynamic study before and 6 months after the both surgery. Success is defined as: no subjective complaint of SUI, negative cough stress test and no leakage on UDS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 5, 2021
CompletedFirst Submitted
Initial submission to the registry
July 2, 2022
CompletedFirst Posted
Study publicly available on registry
July 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 5, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2023
CompletedJuly 7, 2022
March 1, 2022
2 years
July 2, 2022
July 2, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Dryness
Absence of clinical and urodynamic stress incontinence
6 months
Study Arms (2)
Hybrid transobturator tape
EXPERIMENTALAnterior rectus fascia will be exposed and an approximately 8-10 cm × 1 cm strip of rectus fascia will be marked out. The sling will be harvested using sharp dissection. Thereafter, a Polyprolene monofilamentous mesh of 15 cm x 1 cm will be sutured to each edge of the rectus fascia sling that had been harvested. Then, a 2-cm midline incision over the anterior vaginal wall at the level of mid-urethra. A combination of blunt and sharp dissection will be carried out to the obturator foramen bilaterally. Next, a stab incision will be made at a point approximately 2.5 cm infero-lateral to the pubic tubercle bilaterally, corresponding to the level of clitoris. A trocar will be passed through each obturator foramen (outside-in) and the edge of the mesh will be retracted through the incision. Next, the retraction of both meshes will continue until the rectus fascia sling remain flushed with the urethra.
Conventional transobturator tape
ACTIVE COMPARATORThe conventional mesh using mid urethral sling through the trans obturator route
Interventions
Mid urethral sling for treatment of female stress urinary incontinence
Eligibility Criteria
You may qualify if:
- Clinically proven SUI or stress-predominant mixed urinary incontinence by cough stress test.
You may not qualify if:
- Patients with neurogenic voiding dysfunction.
- History of anti-incontinence surgery.
- Presence of urge-predominant mixed urinary incontinence.
- Peripheral neuropathy.
- Multiple sclerosis.
- History of urogenital cancer.
- Pelvic irradiation
- Body mass index more than 40 kg/m2
- The presence of more than stage 2 pelvic organ prolapse as per pelvic organ prolapse quantification (POP-Q) system score.
- Active urinary tract infection
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alexandria Faculty of Medicine
Alexandria, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 2, 2022
First Posted
July 7, 2022
Study Start
January 5, 2021
Primary Completion
January 5, 2023
Study Completion
January 15, 2023
Last Updated
July 7, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share